Jordan O - Search Results

1

Evaluating intimal hyperplasia under clinical conditions.

Mylonaki I, Allain E, Strano F, Allémann E, Corpataux JM, Meda P, Jordan O, Delie F, Rougemont AL, Haefliger JA, Saucy F. Mylonaki I, et al. Among authors: jordan o. Interact Cardiovasc Thorac Surg. 2018 Sep 1;27(3):427-436. doi: 10.1093/icvts/ivy101. Interact Cardiovasc Thorac Surg. 2018. PMID: 29617792

2

The effects of carrier nature and pH on rhBMP-2-induced ectopic bone formation.

Luca L, Rougemont AL, Walpoth BH, Gurny R, Jordan O. Luca L, et al. Among authors: jordan o. J Control Release. 2010 Oct 1;147(1):38-44. doi: 10.1016/j.jconrel.2010.06.011. Epub 2010 Jun 21. J Control Release. 2010. PMID: 20600403

3

Injectable rhBMP-2-loaded chitosan hydrogel composite: osteoinduction at ectopic site and in segmental long bone defect.

Luca L, Rougemont AL, Walpoth BH, Boure L, Tami A, Anderson JM, Jordan O, Gurny R. Luca L, et al. Among authors: jordan o. J Biomed Mater Res A. 2011 Jan;96(1):66-74. doi: 10.1002/jbm.a.32957. Epub 2010 Oct 26. J Biomed Mater Res A. 2011. PMID: 21105153

4

Atorvastatin-loaded hydrogel affects the smooth muscle cells of human veins.

Dubuis C, May L, Alonso F, Luca L, Mylonaki I, Meda P, Delie F, Jordan O, Déglise S, Corpataux JM, Saucy F, Haefliger JA. Dubuis C, et al. Among authors: jordan o. J Pharmacol Exp Ther. 2013 Dec;347(3):574-81. doi: 10.1124/jpet.113.208769. Epub 2013 Sep 26. J Pharmacol Exp Ther. 2013. PMID: 24071735

5

A novel biocompatible hyaluronic acid-chitosan hybrid hydrogel for osteoarthrosis therapy.

Kaderli S, Boulocher C, Pillet E, Watrelot-Virieux D, Rougemont AL, Roger T, Viguier E, Gurny R, Scapozza L, Jordan O. Kaderli S, et al. Among authors: jordan o. Int J Pharm. 2015 Apr 10;483(1-2):158-68. doi: 10.1016/j.ijpharm.2015.01.052. Epub 2015 Feb 7. Int J Pharm. 2015. PMID: 25666331

6

Intra-articular bioactivity of a p38 MAPK inhibitor and development of an extended-release system.

Pradal J, Zuluaga MF, Maudens P, Waldburger JM, Seemayer CA, Doelker E, Gabay C, Jordan O, Allémann E. Pradal J, et al. Among authors: jordan o. Eur J Pharm Biopharm. 2015 Jun;93:110-7. doi: 10.1016/j.ejpb.2015.03.017. Epub 2015 Mar 30. Eur J Pharm Biopharm. 2015. PMID: 25836052

7

Effect of particle size on the biodistribution of nano- and microparticles following intra-articular injection in mice.

Pradal J, Maudens P, Gabay C, Seemayer CA, Jordan O, Allémann E. Pradal J, et al. Among authors: jordan o. Int J Pharm. 2016 Feb 10;498(1-2):119-29. doi: 10.1016/j.ijpharm.2015.12.015. Epub 2015 Dec 10. Int J Pharm. 2016. PMID: 26685724

8

Perivascular sustained release of atorvastatin from a hydrogel-microparticle delivery system decreases intimal hyperplasia.

Mylonaki I, Strano F, Deglise S, Allémann E, Alonso F, Corpataux JM, Dubuis C, Haefliger JA, Jordan O, Saucy F, Delie F. Mylonaki I, et al. Among authors: jordan o. J Control Release. 2016 Jun 28;232:93-102. doi: 10.1016/j.jconrel.2016.04.023. Epub 2016 Apr 16. J Control Release. 2016. PMID: 27091698

9

Perivascular medical devices and drug delivery systems: Making the right choices.

Mylonaki I, Allémann É, Saucy F, Haefliger JA, Delie F, Jordan O. Mylonaki I, et al. Among authors: jordan o. Biomaterials. 2017 Jun;128:56-68. doi: 10.1016/j.biomaterials.2017.02.028. Epub 2017 Feb 28. Biomaterials. 2017. PMID: 28288349 Review.

10

Design and characterization of a perivascular PLGA coated PET mesh sustaining the release of atorvastatin for the prevention of intimal hyperplasia.

Mylonaki I, Trosi O, Allémann E, Durand M, Jordan O, Delie F. Mylonaki I, et al. Among authors: jordan o. Int J Pharm. 2018 Feb 15;537(1-2):40-47. doi: 10.1016/j.ijpharm.2017.12.026. Epub 2017 Dec 12. Int J Pharm. 2018. PMID: 29246440

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page